Mark Anderton is a Director of drug safety within the Oncology Safety department of AstraZeneca. He earned his PhD in Cancer Pharmacology and Toxicology at the MRC Toxicology Unit, Leicester. After his PhD, Mark joined Vertex Pharmaceuticals, UK where he gained experience in all...
Read More →